Tilray Brands Reports $257.1 Million Revenue with 23% Increase, Faces $40 Million Net Loss

Tilray Brands, Inc. reported a net revenue of $257.1 million for the fiscal quarter ending August 31, 2026, marking a 23% increase from $209.5 million in the same period last year. The company's gross profit also rose significantly, reaching $77.5 million, up 35% from $57.5 million a year earlier. However, Tilray experienced a net loss of $40.0 million, compared to a net income of $1.5 million in the prior year, primarily due to increased operating expenses and restructuring costs associated with recent acquisitions.

The company's operating expenses surged to $101.6 million, an 83% increase from $55.4 million in the previous year. This rise was largely attributed to $32 million in incremental costs related to the Global BrewDog Acquisitions and the Lyphe Acquisition, as well as a significant increase in general and administrative expenses. Notably, the absence of a $15 million gain from the change in fair value of contingent consideration recognized in the prior year further impacted the financial results.

In terms of strategic developments, Tilray completed several acquisitions, including BrewDog and Lyphe, which are expected to enhance its market presence and operational capabilities. The BrewDog acquisition, in particular, transformed Tilray's beverage platform from a U.S.-focused business to a global entity, providing access to international markets and a broader consumer base. The company also launched new products in response to evolving consumer preferences, including lower-sugar and non-alcoholic options.

Operationally, Tilray reported a decrease in its Canadian cannabis market share, dropping from 7.9% to 7.4% due to supply chain challenges and increased competition. However, the company saw growth in its international cannabis revenue, which increased to $16.2 million, driven by demand in the German market. The company also redirected inventory to international markets, which is expected to generate higher-margin sales.

Looking ahead, Tilray remains focused on optimizing its cost structure and expanding its product offerings. The company anticipates that its recent acquisitions will yield synergies and enhance profitability in the long term. Additionally, Tilray is actively monitoring regulatory developments in the cannabis sector, particularly in the U.S., which could present new growth opportunities. The company aims to leverage its established infrastructure and expertise to navigate these changes effectively.